Cargando…
Neuroproteome Changes after Ischemia/Reperfusion Injury and Tissue Plasminogen Activator Administration in Rats: A Quantitative iTRAQ Proteomics Study
The thrombolytic, recombinant tissue plasminogen activator (rt-PA) is the only approved therapy for acute ischemic stroke (AIS). When administered after AIS, rt-PA has many adverse pleiotropic actions, which are currently poorly understood. The identification of proteins showing differential express...
Autores principales: | Merali, Zamir, Gao, Meah MingYang, Bowes, Tim, Chen, Jian, Evans, Kenneth, Kassner, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039533/ https://www.ncbi.nlm.nih.gov/pubmed/24879061 http://dx.doi.org/10.1371/journal.pone.0098706 |
Ejemplares similares
-
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
iTRAQ-derived quantitative proteomics uncovers the neuroprotective property of bexarotene in a mice model of cerebral ischemia–reperfusion injury
por: Liu, Hailin, et al.
Publicado: (2022) -
The plasminogen protein is associated with high myopia as revealed by the iTRAQ-based proteomic analysis of the aqueous humor
por: Wen, Kai, et al.
Publicado: (2021) -
iTRAQ-Based Quantitative Proteomic Analysis of the Initiation of Head Regeneration in Planarians
por: Geng, Xiaofang, et al.
Publicado: (2015) -
Quantitative Serum Proteomic Analysis of Essential Hypertension Using iTRAQ Technique
por: Xu, Jing-Wen, et al.
Publicado: (2017)